文献速递美容整形

美容手术中的口服避孕药管理:当前实践趋势调查

Oral Contraceptive Management in Aesthetic Surgery: A Survey of Current Practice Trends.
PubMed 文献 · Aesthet Surg J · 2018-01-01

本研究通过八项在线问卷调查美国整形外科医师学会(ASPS)成员,了解美容手术围手术期口服避孕药(OCP)的管理趋势。共回收220份问卷(应答率11.9%),仅31.8%的医师报告术前或术后停用OCP。尽管OCP是静脉血栓栓塞事件的已知危险因素,多数实施美容手术的医师并不常规建议围手术期停药。

要点

  • 仅31.8%的医师报告术前或术后停用OCP,多数不常规建议围手术期停药。
  • 7.3%仅术前停药,24.5%术前术后均停药,0.0%仅术后停药。
  • 学术实践医师围手术期停药比例无统计学显著差异(P=0.335)。

核心结论

  • 尽管OCP治疗是静脉血栓栓塞事件的已知危险因素,多数实施美容手术的医师并不常规建议围手术期停药。

研究设计与样本

  • 八项在线问卷分发至美国整形外科医师学会(ASPS)成员,共回收220份问卷(应答率11.9%)。

主要发现

  • 仅31.8%的医师报告术前或术后停用OCP。
  • 7.3%的医师仅术前停药,24.5%的医师术前术后均停药,0.0%的医师仅术后停药。
  • 学术实践医师围手术期停药比例无统计学显著差异(P=0.335)。
  • 总体执业年限无统计学显著性(P=0.152)。
  • 三组在每年美容手术数量或手术类型百分比构成上无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oral contraceptive pills (OCPs) are currently used by approximately 16% of all women aged 15 to 44 in the United States and have been used by 80% of all sexually active women at some point in their lives. However, no guidelines exist for discontinuation of OCP therapy before or after elective cosmetic surgery. OBJECTIVES: The aim of this study is to establish current practice trends regarding perioperative OCP management in aesthetic surgery. METHODS: An eight-item online survey was distributed to members of the American Society of Plastic Surgeons (ASPS). Survey results were analyzed to determine if surgeons' practice setting, years of experience, annual cosmetic volume, or types of cosmetic procedures performed affected their perioperative management of OCPs. RESULTS: A total of 220 questionnaires were collected (11.9% response rate). Only 31.8% of surgeons reported any discontinuation of OCPs pre- or postoperatively. Among physicians, 7.3% reported only preoperative discontinuation, 24.5% reported OCP discontinuation both pre- and postoperatively, and 0.0% of physicians reported discontinuation of OCPs only postoperatively. There was no statistically significant difference between the percentage of surgeons in academic practice who discontinue OCPs perioperatively (P = 0.335). There was no statistical significance towards overall years in practice (P = 0.152). There were no significant differences between the three groups in the number of cosmetic procedures performed annually or percentage breakdown of procedures performed. CONCLUSIONS: Despite OCP therapy being a known risk factor for venous thromboembolic events, a majority of surgeons performing cosmetic surgery do not routinely recommend perioperative cessation.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Chattha A, Brown E, Slavin S, et al. Oral Contraceptive Management in Aesthetic Surgery: A Survey of Current Practice Trends. Aesthet Surg J. 2018. PMID: 29267904. doi:10.1093/asj/sjx234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。